MedPath

NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE

NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE logo
๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Recombinant Human Interferon Beta-1a (Avonex) for the Treatment of Patients With HTLV-1-Associated Myelopathy (HAM)

Phase 2
Completed
Conditions
Spinal Cord Disease
Tropical Spastic Paraparesis
HTLV-I Infection
First Posted Date
1999-11-04
Last Posted Date
2008-03-04
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Target Recruit Count
12
Registration Number
NCT00001785
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, Maryland, United States

Analysis of the Nervous System in Patients With Fabry's Disease

Completed
Conditions
Fabry's Disease
First Posted Date
1999-11-04
Last Posted Date
2017-07-02
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Target Recruit Count
325
Registration Number
NCT00001491
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Sensory Function in Idiopathic Voice Disorders

Completed
Conditions
Voice Disorder
Phonation Disorder
Spastic Dysphonia
First Posted Date
1999-11-04
Last Posted Date
2017-07-02
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Target Recruit Count
370
Registration Number
NCT00001922
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Effects of Enzyme Replacement in Gaucher's Disease

Completed
Conditions
Gaucher's Disease
First Posted Date
1999-11-04
Last Posted Date
2017-07-02
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Target Recruit Count
70
Registration Number
NCT00001289
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Sleep Disorders of Patients With Diseases of the Nervous System

Completed
Conditions
Hypersomnia
Nervous System Disease
Narcolepsy
Sleep Disorder
First Posted Date
1999-11-04
Last Posted Date
2017-07-02
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Target Recruit Count
83
Registration Number
NCT00001664
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Evaluation of Patients With HAM/TSP

Recruiting
Conditions
HTLV-I Infection
Tropical Spastic Paraparesis
First Posted Date
1999-11-04
Last Posted Date
2025-05-18
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Target Recruit Count
750
Registration Number
NCT00001778
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Diagnosis and History Study of Patients With Different Neurological Conditions

Completed
Conditions
Healthy Volunteer
Nervous System Disease
First Posted Date
1999-11-04
Last Posted Date
2025-05-20
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Target Recruit Count
3813
Registration Number
NCT00001367
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)

Recruiting
Conditions
Multiple Sclerosis
First Posted Date
1999-11-04
Last Posted Date
2025-05-20
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Target Recruit Count
2500
Registration Number
NCT00001248
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Oxandrolone Compared With a Placebo on Growth Rate in Girls With Growth Hormone-Treated Turner's Syndrome

Phase 2
Completed
Conditions
Turner's Syndrome
First Posted Date
1999-10-19
Last Posted Date
2008-09-10
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Target Recruit Count
80
Registration Number
NCT00004275
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Phase III Randomized Study of Diazepam Vs Lorazepam Vs Placebo for Prehospital Treatment of Status Epilepticus

Phase 3
Completed
Conditions
Status Epilepticus
First Posted Date
1999-10-19
Last Posted Date
2005-06-24
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Target Recruit Count
210
Registration Number
NCT00004297
ยฉ Copyright 2025. All Rights Reserved by MedPath